Interleukin-6-induced protection in hyperoxic acute lung injury

Am J Respir Cell Mol Biol. 2000 May;22(5):535-42. doi: 10.1165/ajrcmb.22.5.3808.

Abstract

Hyperoxic lung injury is commonly encountered in patients who require treatment with high concentrations of inspired oxygen. To determine whether interleukin (IL)-6 is protective in oxygen toxicity, we compared the effects of 100% O(2) in transgenic mice that overexpress IL-6 in the lung and transgene (-) controls. IL-6 markedly enhanced survival, with 100% of transgene (-) animals dying within 72 to 96 h, 100% of transgene (+) animals living for more than 8 d and more than 90% of transgene (+) animals living longer than 12 d. This protection was associated with markedly diminished alveolar-capillary protein leak, endothelial and epithelial membrane injury, and lung lipid peroxidation. Hyperoxia also caused cell death with DNA fragmentation in the lungs of transgene (-) animals and IL-6 markedly diminished this cytopathic response. The protective effects of IL-6 were not associated with significant alterations in the activities of copper/ zinc superoxide dismutase (SOD) or manganese SOD. They were, however, associated with the enhanced accumulation of the cell-death inhibitor Bcl-2, but not the cell-death stimulator BAX, and with the heightened accumulation of the cell-death regulator tissue inhibitor of metalloproteinase-1 (TIMP-1). These studies demonstrate that IL-6 markedly diminishes hyperoxic lung injury and that this protection is associated with a marked diminution in hyperoxia-induced cell death and DNA fragmentation. They also demonstrate that this protection is not associated with significant alterations in SOD activity, but is associated with the induction of Bcl-2 and TIMP-1.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antioxidants / metabolism
  • Apoptosis / drug effects
  • Apoptosis / genetics
  • Bronchoalveolar Lavage Fluid / cytology
  • Cells, Cultured
  • Hyperoxia / genetics*
  • Hyperoxia / mortality
  • In Situ Nick-End Labeling
  • Interleukin-6 / genetics*
  • Interleukin-6 / pharmacology
  • Lipid Peroxidation / drug effects
  • Lipid Peroxidation / genetics
  • Lung / drug effects*
  • Lung / pathology
  • Mice
  • Mice, Transgenic
  • Microscopy, Electron
  • Proto-Oncogene Proteins / metabolism
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • Superoxide Dismutase / metabolism
  • Tissue Inhibitor of Metalloproteinase-1 / metabolism
  • bcl-2-Associated X Protein

Substances

  • Antioxidants
  • Bax protein, mouse
  • Interleukin-6
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-bcl-2
  • Tissue Inhibitor of Metalloproteinase-1
  • bcl-2-Associated X Protein
  • Superoxide Dismutase